Well preserved functional status in patients with Guillain-Barré polyradiculoneuritis and severe electrophysiological abnormalities;Estado funcional bien preservado en pacientes con polirradiculoneuritis de Guillain-Barré y anomalías electrofisiológicas graves

Revista de Neurologia

Volumn 46, Issue 3, 2008, Pages 186-188

  Cindro, V V ^a  

^a Hospital Clínico de Split   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; PREDNISONE;

CORRELATION ANALYSIS; ELECTRODIAGNOSIS; ELECTROPHYSIOLOGY; FUNCTIONAL ASSESSMENT; GUILLAIN BARRE SYNDROME; IMMUNOLOGY; LETTER; PROGNOSIS;

EID: 40849094580     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4603.2007453     Document Type: Letter

References (22)

1. Ropper AH, Wijdicks EFM, Truax BT. Guillain-Barré syndrome. Contemporary Neurology Series no. 34. Philadelphia: F.A. Davis; 1991. p. 1-369.
2. Ng KK, Howard RS, Fish DR, Hirsch NP, Wiles CM, Murray NM, et al. Management and outcome of severe Guillain-Barré syndrome. Q J Med 1995; 88: 243-50.
3. Bogliun G, Beghi E. Incidence and clinical features of acute inflammatory polyradiculoneuropathy in Lombardy, Italy, 1996. Acta Neurol Scand 2004; 110: 100-6.
4. The Italian Guillain-Barré Study Group. The prognosis and main prognostic indicators of Guillain-Barré syndrome. A multicentre- prospective study of 297 patients. Brain 1996; 119: 2053-61.
5. Hinmann R, Magee R. Guillain-Barré syndrome with slow progressive onset and persistent elevation of spinal fluid protein. Ann Intern Med 1967; 67: 1007-112.
6. Ohkoshi N, Harada K, Nagata H, Yato M, Shoji S. Ataxic form of chronic inflammatory demyelinating polyradiculoneuropathy. Clinical features and pathological study of the sural nerves. Eur Neurol 2001; 45: 241-8.
7. Rees H, Thompson D, Smeeton C, Hughes C. Epidemiological study of Guillain-Barré syndrome in South England. J Neurol Neurosurg Psychiatry 1998; 64: 74-7.
8. Lawn D, Wijdicks M. Fatal Guillain-Barré syndrome. Neurology 1989; 52: 635-8.
9. Dyck J, Karnes L, Lambert H. Longitudinal study of neuropathic deficit and nerve conduction abnormalities in hereditary motor and sensory neuropathy type I. Neurology 1989; 39: 1302-8.
10. Jušic A, Vrebalov V. Electrophysiologic signs of sensory and motor nerve fibres damage with preserved ability of complex and precise movements in patients with hereditary motor and sensory neuropathy. New trends in neuromuscular diseases and electromyography. Zagreb: Skolska Knjiga; 1989. p. 462-6.
11. Naisonobe T, Chassanade B, Verin M, Jouni M, Leger M, Bousce P. Chronic dysimmune demyelinating polyneuropathy: a clinical and electrophysiological study of 93 patients. J Neurol Neurosurg Psychiatry 1996; 61: 36-42.
12. Thomas K, Lascells G, Hallpike F, Hewer L. Recurrent and chronic relapsing Guillain-Barré polyneuritis. Brain 1969; 92: 589-606.
13. Bergner M, Bobbit A, Carter B, Gilson S. The Sickness Impact Profile; development and final revision of a health status measure. Med Care 1981; 19: 787-805.
14. Koul R, Chacko A, Ahmed R. Ten-year prospective study (clinical spectrum) of childhood Guillain-Barré syndrome in the Arabian Peninsula: comparison of outcome in patients in the pre- and post-intravenous immunoglobulin eras. J Child Neurol 2003; 18: 767-71.
15. Romano JG, Rotta FT, Potter P, Rosenfeld V, Santibáñez R, Rocha B, et al. Relapses in the Guillain-Barré syndrome after treatment with intravenous immunoglobulin or plasma exchange. Muscle Nerve 1998; 21: 1327-30.
16. DiMaria FJ. Intravenous immunoglobulin treatment of childhood Guillain-Barré syndrome. Pediatrics 2003; 116: 226-8.
17. Yata J, Nihei K, Ohya T, Hirano Y, Momoi M, Maekawa K, et al. High-dose immunoglobulin therapy for Guillain-Barré syndrome in Japanese children. Study group for Pediatric Guillain-Barré syndrome. Pediatr Int 2003; 45: 543-9.
18. Sarkey J, Richards M, Stubs E. Lovostatin attenuates injury in an animal model of Guillain-Barré syndrome. J Neurochem 2007; 100: 1265-6.
19. Griffin W, Li Cy, Ho W. Pathology of the motor-sensory axonal Guillain-Barré syndrome. Ann Neurol 1996; 39: 17-28.
20. Asbury K, Arnason G, Adams D. The inflammatory lesion in idiopathic polyneuritis: its role in pathogenesis. Medicine 1969; 48: 173-215.
21. Trapp D, Person J, Rasohoff M, Rudick R, Mork S, Bo L. Axonal transaction in the lesions of multiple sclerosis N Engl J Med 1998; 338: 278-85.
22. Bouchard C, Lacroix C, Planté V, Adams D. Clinicopatologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology 1999; 52: 498-503.